Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients.
Laminar cortical damage in multiple sclerosis.
Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.
Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity.
[Efficacy and tolerability of long-term using of glatimer acetate (copaxone): a 10 year-study in the Moscow Municipal Multiple Sclerosis center.]
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis.
Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
NMO-IgG positive relapsing longitudinally extensive transverse myelitis (LETM) in a seropositive HIV patient.
PDE4B as a microglia target to reduce neuroinflammation.
Simulating neurodegeneration through longitudinal population analysis of structural and diffusion weighted MRI data.
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis.
Small and Long Regulatory RNAs in the Immune System and Immune Diseases.
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
A mechanism-based classification of pain in multiple sclerosis.
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
[A different approach to the care of patients with MS].
Signalling Pathways that Inhibit the Capacity of Precursor Cells for Myelin Repair.

Pages